Financials

  • Market Capitalization 107.71 M
  • Employee 183
  • Founded 1995
  • CEO Sandy Macrae
  • Website www.sangamo.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHYT80
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.95
売上高対価格比率
2.98

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

ニュース